In conclusion, the present study showed Synta66 to be (i) a selective pore inhibitor of the Orai1 channel that mediates its effects by binding close to the selectivity filter, and (ii) an efficient inhibitor of SOCE in GBM cells. This evidence concerns the gene ORAI1 and glioblastoma.